Supplementary Figure S2 from Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab

crossref(2023)

引用 0|浏览4
暂无评分
摘要

Enrichment plots of significantly enriched gene sets for the comparison between active d16HER2 tumors and inactive or negative d16HER2 tumors.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要